\(
\def\WIPO{World Intellectual Property Organisation}
\)
European patent opposition outcomes in biotechnology.
2023
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Détails
Titre
European patent opposition outcomes in biotechnology.
Type d’élément
Journal article
Description
1 volume.
Résumé
Oppositions to patent grants are a means to attack competitors and protect a firm's own patent portfolio. Extant literature has analyzed the determinants of oppositions, while the drivers of opposition outcomes are less known. We study 290 EPO biotech patent oppositions filed in 2012–2019. There are three possible outcomes of opposition proceedings: patent revocation, patent amendment, and opposition rejection. We find that opponents who know the patent's technology are more likely to obtain a patent revocation, while opponents who compete in the product market with the patent owner are more likely to receive a rejection.
Source of Description
Crossref
Série
World Patent Information ; 73, June, 2023.
Dans
World Patent Information
Ressources liées
Publié
Oxford [England] : Elsevier Ltd., 2023
Langue
Anglais
Informations relatives au droit d’auteur
https://www.sciencedirect.com/science/article/abs/pii/S0172219023000108
Le document apparaît dans